Cetuximab: still an option in the treatment of pancreatic cancer?

Author： Faloppi Luca   Andrikou Kalliopi   Cascinu Stefano  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.13, Iss.5, 2013-05, pp. : 791-801

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cetuximab in the treatment of patients with colorectal cancer

By Garrett Christopher R   Eng Cathy  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 937-949

Informa Healthcare

Access to resources Recommend Favorite

The role of cetuximab in the treatment of squamous cell cancer of the head and neck

By Burtness Barbara  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 8, 2005-08 ,pp. : 1085-1093

Informa Healthcare

Access to resources Recommend Favorite

Cetuximab in non-melanoma skin cancer

By Wollina Uwe  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 7, 2012-07 ,pp. : 949-956

Informa Healthcare

Access to resources Recommend Favorite

Effect of combined treatment with recombinant interleukin-2 and allicin on pancreatic cancer

By Wang Cong-Jun   Wang Chao   Han Jiang   Wang Yong-Kun   Tang Lin   Shen Dong-Wei   Zhao Yi   Xu Rong-Hua   Zhang Hui  

Molecular Biology Reports, Vol. 40, Iss. 12, 2013-12 ,pp. : 6579-6585

Springer Publishing Company

Access to resources Recommend Favorite

Cetuximab in non-small cell lung cancer

By Ademuyiwa Foluso O   Hanna Nasser  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 1, 2008-01 ,pp. : 107-113

Informa Healthcare

Access to resources Recommend Favorite